[HTML][HTML] Auger electrons for cancer therapy–a review

A Ku, VJ Facca, Z Cai, RM Reilly - EJNMMI radiopharmacy and chemistry, 2019 - Springer
Abstract Background Auger electrons (AEs) are very low energy electrons that are emitted
by radionuclides that decay by electron capture (eg 111 In, 67 Ga, 99m Tc, 195m Pt, 125 I …

The amazing world of auger electrons

AI Kassis - International journal of radiation biology, 2004 - Taylor & Francis
Over the past 40 years, a small and highly committed group of scientists has pursued
various investigations focused on understanding the physical phenomena underlying the …

Radionuclide therapy with iodine-125 and other auger–electron-emitting radionuclides: Experimental models and clinical applications

L Bodei, AI Kassis, SJ Adelstein… - Cancer Biotherapy and …, 2003 - liebertpub.com
Auger-electron emitters represent an attractive alternative to beta-particle emitters for cancer
therapy if they can be placed intracellularly, especially in close proximity to (or within) …

Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors

RF Barth, W Yang, AS Al-Madhoun, J Johnsamuel… - Cancer research, 2004 - AACR
The purpose of the present study was to evaluate both in vitro and in vivo a series of boron-
containing nucleosides that potentially could be used as delivery agents for neutron capture …

Biophysical aspects of Auger processes

KG Hofer - Acta Oncologica, 1996 - Taylor & Francis
Radionuclide decay by electron capture and/or internal conversion is accompanied by
complex atomic vacancy cascades and emission of low-energy electrons, resulting in a …

Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy

R Onoue, H Watanabe, M Ono - Chemical Communications, 2023 - pubs.rsc.org
Targeted radionuclide therapy using Auger electrons is a promising strategy in cancer
treatment. A DNA-binding Hoechst-tagged radioiodinated BODIPY derivative ([125I] BH) has …

First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX Plus 125IUdR

C Rebischung, D Hoffmann, L Stefani… - … journal of radiation …, 2008 - Taylor & Francis
Purpose: Neoplastic meningitis is often the final outcome of disseminated cancer and is
rapidly lethal. Its limited treatment relies on systemic or intrathecal chemotherapy with …

Ultrasmall Gold Nanoparticles Radiolabeled with Iodine-125 as Potential New Radiopharmaceutical

R Wang, H Liu, B Antal, HT Wolterbeek… - ACS Applied Bio …, 2024 - ACS Publications
The relatively high linear energy transfer of Auger electrons, which can cause clustered DNA
damage and hence efficient cell death, makes Auger emitters excellent candidates for …

Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model

RJ Mairs, CL Wideman, WJ Angerson… - British journal of …, 2000 - nature.com
The Auger electron emitting agent 5-[125 I] iodo-2′-deoxyuridine (ie [125 I] IUdR) holds
promise for the treatment of residual glioma after surgery because this thymidine analogue …

In Vivo Therapy of Neoplastic Meningitis with Methotrexate and 5-[125I]iodo-2'-deoxyuridine

AI Kassis, BA Dahman, JS Adelstein - Acta Oncologica, 2000 - Taylor & Francis
In Vivo Therapy of Neoplastic Meningitis with Methotrexate and 5-[<sup>125</sup>I]iodo-2&apos;-deoxyuridine
Page 1 In Vivo Therapy of Neoplastic Meningitis with Methotrexate and 5-[125I]iodo-2Æ-deoxyuridine …